Fig. 2From: Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaThe downregulation of ALDOB serves as prognostic marker in patients with HCC. a and b The low ALDOB expression group had a shorter RFS and a shorter OS than the high ALDOB expression group. The prognostic significance was assessed by Kaplan–Meier survival estimates and a log-rank test. ALDOB downregulation also indicated worse RFS and OS patients with in BCLC0-A stage (c and d) or TNM I stage tumors (e and f)Back to article page